AU7755591A - The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders - Google Patents

The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders

Info

Publication number
AU7755591A
AU7755591A AU77555/91A AU7755591A AU7755591A AU 7755591 A AU7755591 A AU 7755591A AU 77555/91 A AU77555/91 A AU 77555/91A AU 7755591 A AU7755591 A AU 7755591A AU 7755591 A AU7755591 A AU 7755591A
Authority
AU
Australia
Prior art keywords
hypertension
treatment
vascular disorders
synthetic metalloporphyrins
metalloporphyrins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77555/91A
Inventor
Nader G. Abraham
Attallah Kappas
Richard D Levere
Michel L Schwartzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of AU7755591A publication Critical patent/AU7755591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU77555/91A 1990-04-24 1991-04-18 The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders Abandoned AU7755591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51375190A 1990-04-24 1990-04-24
US513751 1990-04-24

Publications (1)

Publication Number Publication Date
AU7755591A true AU7755591A (en) 1991-11-11

Family

ID=24044543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77555/91A Abandoned AU7755591A (en) 1990-04-24 1991-04-18 The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders

Country Status (2)

Country Link
AU (1) AU7755591A (en)
WO (1) WO1991016053A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
AU2001243578A1 (en) * 2000-03-10 2001-09-24 The Rockefeller University Modulation of cardiovascular injury
US6790463B2 (en) * 2001-03-30 2004-09-14 Robert F. Hofmann Uses of targeted oxidative therapeutic formulation in arteriosclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684637A (en) * 1981-07-15 1987-08-04 The Rockefeller University Method of decreasing rate of heme metabolism
JPS63501219A (en) * 1986-02-21 1988-05-12 ザ　ロツクフエラ−　ユニバ−シテイ Parenterally administered therapeutic composition and method for inhibiting endocrine hormone production
US4997828A (en) * 1989-02-14 1991-03-05 The Rockefeller University Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin

Also Published As

Publication number Publication date
WO1991016053A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
AU673703B2 (en) Injector and use of the same
EP0622063A3 (en) Disposable absorbent articles and methods of making same.
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU4342989A (en) Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics
AU639284B2 (en) The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
AU2140492A (en) Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
OA09362A (en) "Production and use of porphyrins".
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
AU1265295A (en) Reducing likelihood of vascular disorders in susceptible patients
AU8427091A (en) Gamma-carboxylase and methods of use
EP0437026A3 (en) Use of tandospirone in the treatment of depression
EP0488107A3 (en) Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU2992492A (en) The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects
AU7755591A (en) The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
AU1485197A (en) Diamines in the treatment of arrhythmia